Trehalose and aortic inflammatio

Phase 2

Recruiting

• Conditions: Aortic inflammation in patients with cancer.; Arteritis, unspecified; I77.6

• Registration Number: IRCT20130829014521N20
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

Cancer patients with aortic inflammation with a cutoff of 1.6 or more for the TBR in the first scan

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigation of aortic inflammation with (18F-FDG PET) scan. Timepoint: one week after administration of trehalose. Method of measurement: (18F-FDG PET) scan.